METHYLOMIC BIOMARKERS OF SCHIZOPHRENIA AND ANTIPSYCHOTIC MEDICATION EXPOSURE

被引：0

作者：

Hannon, Eilis ^{[1
]}

Dempster, Emma ^{[2
]}

Mansell, Georgina ^{[2
]}

Schalkwyk, Leo ^{[3
]}

Murray, Robin ^{[4
]}

McQuillin, Andrew ^{[5
]}

Kowalec, Kaarina ^{[6
]}

St Clair, David ^{[7
]}

Morris, Derek ^{[8
]}

Sullivan, Patrick ^{[9
]}

O'Donovan, Michael ^{[10
]}

MacCabe, James ^{[11
]}

Collier, David ^{[12
]}

Mill, Jonathan ^{[2
]}

机构：

[1] Univ Exeter, Sch Med, Exeter, Devon, England

[2] Univ Exeter, Exeter, Devon, England

[3] Univ Essex, Colchester, Essex, England

[4] Inst Psychiat, London, England

[5] UCL, London, England

[6] Karolinska Inst, Stockholm, Sweden

[7] Univ Aberdeen, Aberdeen, Scotland

[8] Natl Univ Ireland Galway, Sch Psychol, Neuroimaging & Cognit Genom NICOG Ctr, Galway, Ireland

[9] Univ N Carolina, Chapel Hill, NC 27515 USA

[10] Cardiff Univ, Cardiff, S Glam, Wales

[11] Kings Coll London, London, England

[12] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷

关键词：

D O I：

10.1016/j.euroneuro.2018.08.064

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1099 / 1100

页数：2

共 50 条

[41] Sleep quality in schizophrenia and the effects of atypical antipsychotic medication
Haffmans, PMJ
Oolders, HJ
Hoencamp, E
Schreiner, A
ACTA NEUROPSYCHIATRICA, 2004, 16 (06): : 281 - 289
[42] Long-Acting Antipsychotic Medication and the Outcome of Schizophrenia
David, Anthony S.
Gibbs, Ayana
Patel, Maxine X.
ADVANCES IN SCHIZOPHRENIA RESEARCH 2009, 2010, : 403 - +
[43] A comparative study of antipsychotic medication taking in people with schizophrenia
McCann, Terence V.
Deans, Cecil
Clark, Eileen
Lu, Sai
INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2008, 17 (06) : 428 - 438
[44] Antipsychotic medication and social cue recognition in chronic schizophrenia
Roberts, David Leland
Penn, David Lewis
Corrigan, Patrick
Lipkovich, Ilya
Kinon, Bruce
Black, Ryan Andrew
PSYCHIATRY RESEARCH, 2010, 178 (01) : 46 - 50
[45] Dimensions of schizophrenia; Antipsychotic medication and serum monoamine activity
Oades, RD
Henning, U
Klimke, A
Rao, ML
SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 66 - 67
[46] A Prototype Approach Toward Antipsychotic Medication Adherence in Schizophrenia
Freudenreich, Oliver
Tranulis, Constantin
HARVARD REVIEW OF PSYCHIATRY, 2009, 17 (01) : 35 - 40
[47] Second-generation antipsychotic medication combinations for schizophrenia
Eisen, Carol
Shaner, Roderick
Unutzer, Jurgen
Fink, Arlene
Wells, Kenneth B.
PSYCHIATRIC SERVICES, 2008, 59 (03) : 235 - 235
[48] Antipsychotic medication and treatment outcome in schizophrenia outpatient care
Seemann, U
Schwarz, C
Janssen, B
Kissling, W
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S297 - S297
[49] Risperidone versus other atypical antipsychotic medication for schizophrenia
William T. Carpenter
Current Psychiatry Reports, 2000, 2 (5) : 375 - 375
[50] Antipsychotic Medication Adherence in Patients with Schizophrenia or Schizoaffective Disorder
Reutfors, Johan
Brandt, Lena
Stephansson, Olof
Kieler, Helle
Andersen, Morten
Boden, Robert
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 437 - 438

← 1 2 3 4 5 →